Nasdaq

Abbott's FreeStyle® Libre 2 iCGM System Now Available to Medicare Beneficiaries

- U.S. Centers for Medicare & Medicaid Services (CMS) reimbursement expands access of the FreeStyle Libre 2 system to Medicare patients[1] to better manage their diabetes - The FreeStyle Libre 2 ...
Monthly Prescribing Reference

FreeStyle Libre 2 Cleared for Use in Adults and Pediatric Patients With Diabetes

The FDA has approved the FreeStyle® Libre 2 integrated continuous glucose monitoring system (Abbott) for adults and children ≥4 years of age with diabetes. The Food and Drug Administration (FDA) has ...
PharmiWeb

MILITARY MEMBERS, FAMILIES AND RETIREES GET SIMPLIFIED ACCESS TO ABBOTT’S FREESTYLE® LIBRE 2 SYSTEM THROUGH TRICARE®

- TRICARE members now have faster, easier, and more convenient access to continuous glucose monitoring - Abbott’s FreeStyle Libre 2 system will now be on the brand-name formulary and available through ...
Nasdaq

Abbott's FreeStyle Libre® 2 Receives National Reimbursement in France for All People with Diabetes Who Use Insulin¹

ABBOTT PARK, Ill., June 22, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the French health authority has approved the expansion of reimbursement coverage for its FreeStyle Libre 2 ...
Newswire

Abbott's FreeStyle Libre® 2 System Now Reimbursed in Quebec

"The best healthcare solution is the one that helps the most people, which is why we designed our FreeStyle Libre portfolio with access and affordability in mind from the very beginning," said ...